These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

462 related articles for article (PubMed ID: 2668761)

  • 1. Islet amyloid, islet-amyloid polypeptide, and diabetes mellitus.
    Johnson KH; O'Brien TD; Betsholtz C; Westermark P
    N Engl J Med; 1989 Aug; 321(8):513-8. PubMed ID: 2668761
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Islet amyloid polypeptide: mechanisms of amyloidogenesis in the pancreatic islets and potential roles in diabetes mellitus.
    Johnson KH; O'Brien TD; Betsholtz C; Westermark P
    Lab Invest; 1992 May; 66(5):522-35. PubMed ID: 1573849
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Islet pathology of non-insulin-dependent diabetes mellitus (NIDDM).
    Westermark P
    Diabet Med; 1996 Sep; 13(9 Suppl 6):S46-8. PubMed ID: 8894481
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Islet amyloid polypeptide, islet amyloid, and diabetes mellitus.
    Westermark P; Andersson A; Westermark GT
    Physiol Rev; 2011 Jul; 91(3):795-826. PubMed ID: 21742788
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Islet amyloid polypeptide: a review of its biology and potential roles in the pathogenesis of diabetes mellitus.
    O'Brien TD; Butler PC; Westermark P; Johnson KH
    Vet Pathol; 1993 Jul; 30(4):317-32. PubMed ID: 8212454
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Amyloidogenicity and cytotoxicity of islet amyloid polypeptide.
    Kapurniotu A
    Biopolymers; 2001; 60(6):438-59. PubMed ID: 12209476
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Role of IAPP in the pathogenesis and development of NIDDM].
    Sanke T; Nishi M; Nanjo K
    Nihon Rinsho; 1994 Oct; 52(10):2737-45. PubMed ID: 7983807
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Extensive islet amyloid formation is induced by development of Type II diabetes mellitus and contributes to its progression: pathogenesis of diabetes in a mouse model.
    Höppener JW; Oosterwijk C; Nieuwenhuis MG; Posthuma G; Thijssen JH; Vroom TM; Ahrén B; Lips CJ
    Diabetologia; 1999 Apr; 42(4):427-34. PubMed ID: 10230646
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Construction of transgenic mouse system expressing human islet amyloid polypeptide (IAPP)/amylin].
    Yagui K; Kanatsuka A; Makino H
    Nihon Rinsho; 1994 Oct; 52(10):2746-50. PubMed ID: 7983808
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Beta-cell deficit due to increased apoptosis in the human islet amyloid polypeptide transgenic (HIP) rat recapitulates the metabolic defects present in type 2 diabetes.
    Matveyenko AV; Butler PC
    Diabetes; 2006 Jul; 55(7):2106-14. PubMed ID: 16804082
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Marked islet amyloid polypeptide-positive amyloid deposition: a possible cause of severely insulin-deficient diabetes mellitus with atrophied exocrine pancreas.
    Sugawara K; Kobayashi T; Nakanishi K; Kajio H; Ohkubo M; Sugimoto T; Murase T; Itoh T; Hara M; Kosaka K
    Pancreas; 1993 May; 8(3):312-5. PubMed ID: 8483872
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An in vitro model of early islet amyloid polypeptide (IAPP) fibrillogenesis using human IAPP-transgenic mouse islets.
    Henson MS; Buman BL; Jordan K; Rahrmann EP; Hardy RM; Johnson KH; O'Brien TD
    Amyloid; 2006 Dec; 13(4):250-9. PubMed ID: 17107885
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impaired glucose tolerance is associated with increased islet amyloid polypeptide (IAPP) immunoreactivity in pancreatic beta cells.
    Johnson KH; O'Brien TD; Jordan K; Westermark P
    Am J Pathol; 1989 Aug; 135(2):245-50. PubMed ID: 2675614
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Altered immunoreactivity of islet amyloid polypeptide (IAPP) may reflect major modifications of the IAPP molecule in amyloidogenesis.
    Ma Z; Westermark GT; Li ZC; Engström U; Westermark P
    Diabetologia; 1997 Jul; 40(7):793-801. PubMed ID: 9243100
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Canine IAPP cDNA sequence provides important clues regarding diabetogenesis and amyloidogenesis in type 2 diabetes.
    Jordan K; Murtaugh MP; O'Brien TD; Westermark P; Betsholtz C; Johnson KH
    Biochem Biophys Res Commun; 1990 Jun; 169(2):502-8. PubMed ID: 2192709
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biological action of pancreatic amylin: relationship with glucose metabolism, diabetes, obesity and calcium metabolism.
    Koopmans SJ; Radder JK; Krans HM; Barge RM
    Neth J Med; 1992 Aug; 41(1-2):82-90. PubMed ID: 1407245
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ferret islet amyloid polypeptide (IAPP): characterization of in vitro and in vivo amyloidogenicity.
    Paulsson JF; Benoit-Biancamano MO; Schäffer L; Dahl K
    Amyloid; 2011 Dec; 18(4):222-8. PubMed ID: 22047620
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Toxic human islet amyloid polypeptide (h-IAPP) oligomers are intracellular, and vaccination to induce anti-toxic oligomer antibodies does not prevent h-IAPP-induced beta-cell apoptosis in h-IAPP transgenic mice.
    Lin CY; Gurlo T; Kayed R; Butler AE; Haataja L; Glabe CG; Butler PC
    Diabetes; 2007 May; 56(5):1324-32. PubMed ID: 17353506
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High prevalence of pancreatic islet amyloid in patients with end-stage renal failure on dialysis treatment.
    de Koning EJ; Fleming KA; Gray DW; Clark A
    J Pathol; 1995 Feb; 175(2):253-8. PubMed ID: 7738722
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High expression rates of human islet amyloid polypeptide induce endoplasmic reticulum stress mediated beta-cell apoptosis, a characteristic of humans with type 2 but not type 1 diabetes.
    Huang CJ; Lin CY; Haataja L; Gurlo T; Butler AE; Rizza RA; Butler PC
    Diabetes; 2007 Aug; 56(8):2016-27. PubMed ID: 17475933
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.